Total Payments
$1,944
2024 Payments
$549.48
Companies
19
Transactions
84
Medicare Patients
3,785
Medicare Billing
$155,163
Payment Breakdown by Category
Food & Beverage$1,734 (89.2%)
Education$209.95 (10.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,734 | 80 | 89.2% |
| Education | $209.95 | 4 | 10.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $487.93 | 21 | $0 (2024) |
| Davol Inc. | $255.91 | 2 | $0 (2021) |
| ABBVIE INC. | $208.86 | 11 | $0 (2024) |
| PFIZER INC. | $189.28 | 10 | $0 (2024) |
| Janssen Biotech, Inc. | $175.11 | 5 | $0 (2024) |
| UCB, Inc. | $119.27 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $111.04 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $65.03 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $54.15 | 3 | $0 (2023) |
| Aurinia Pharma U.S., Inc. | $42.43 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $549.48 | 25 | Amgen Inc. ($160.15) |
| 2023 | $613.73 | 29 | Amgen Inc. ($220.40) |
| 2022 | $401.21 | 22 | Amgen Inc. ($107.38) |
| 2021 | $270.61 | 7 | Davol Inc. ($146.56) |
| 2020 | $109.35 | 1 | Davol Inc. ($109.35) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Bone Health | ||||||
| 09/06/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological), NUCALA | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Immunology | ||||||
| 08/12/2024 | SOBI, INC | KINERET (Drug) | Education | In-kind items and services | $19.25 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Dermatology | ||||||
| 06/28/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $32.65 | General |
| Category: Inflammation | ||||||
| 06/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 06/21/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Inflammation | ||||||
| 06/07/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Bone Health | ||||||
| 04/27/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological), NUCALA | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: IMMUNOLOGY | ||||||
| 04/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Not Applicable | ||||||
| 04/09/2024 | SOBI, INC | KINERET (Drug) | Education | In-kind items and services | $19.25 | General |
| Category: IMMUNOLOGY | ||||||
| 03/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Immunology | ||||||
| 03/22/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Endocrinology | ||||||
| 03/08/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: Immunology | ||||||
| 02/23/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 02/16/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Inflammation | ||||||
| 02/09/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Immunology | ||||||
| 02/02/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: IMMUNOLOGY | ||||||
| 01/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Bone Health | ||||||
| 01/19/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Inflammation | ||||||
| 01/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.93 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,764 | 2,864 | $237,514 | $73,441 |
| 2022 | 18 | 1,419 | 2,330 | $162,677 | $60,362 |
| 2021 | 13 | 602 | 821 | $52,790 | $21,359 |
Total Patients
3,785
Total Services
6,015
Medicare Billing
$155,163
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 195 | 412 | $64,915 | $34,216 | 52.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 145 | 145 | $35,170 | $14,514 | 41.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 249 | 249 | $62,250 | $8,518 | 13.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 229 | 465 | $6,975 | $3,698 | 53.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 195 | 399 | $15,960 | $2,873 | 18.0% |
| 80076 | Liver function blood test panel | Office | 2023 | 134 | 264 | $13,200 | $2,031 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 27 | $2,905 | $1,708 | 58.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 74 | 123 | $7,380 | $1,242 | 16.8% |
| 82565 | Blood creatinine level | Office | 2023 | 125 | 243 | $7,290 | $1,172 | 16.1% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 24 | 46 | $4,110 | $994.54 | 24.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 28 | 28 | $3,080 | $812.28 | 26.4% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 99 | 169 | $4,225 | $425.46 | 10.1% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 57 | 87 | $3,480 | $419.38 | 12.1% |
| 84550 | Uric acid level, blood | Office | 2023 | 29 | 40 | $1,200 | $174.00 | 14.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 31 | 33 | $822.00 | $157.48 | 19.2% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 21 | 26 | $780.00 | $136.65 | 17.5% |
| 86431 | Rheumatoid factor level | Office | 2023 | 25 | 25 | $1,949 | $133.44 | 6.8% |
| 84156 | Total protein level, urine | Office | 2023 | 31 | 33 | $825.00 | $111.60 | 13.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 46 | 50 | $998.00 | $103.40 | 10.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 160 | 348 | $53,940 | $29,272 | 54.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 160 | 160 | $38,400 | $16,876 | 43.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 183 | 355 | $14,180 | $2,640 | 18.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 120 | 200 | $12,000 | $2,051 | 17.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 28 | $2,940 | $1,769 | 60.2% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2022 | 36 | 71 | $6,210 | $1,614 | 26.0% |
About Dr. Daniel Grant, MD
Dr. Daniel Grant, MD is a Rheumatology healthcare provider based in Rome, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2016. The National Provider Identifier (NPI) number assigned to this provider is 1114377207.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Grant, MD has received a total of $1,944 in payments from pharmaceutical and medical device companies, with $549.48 received in 2024. These payments were reported across 84 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,734).
As a Medicare-enrolled provider, Grant has provided services to 3,785 Medicare beneficiaries, totaling 6,015 services with total Medicare billing of $155,163. Data is available for 3 years (2021–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Rome, GA
- Active Since 06/20/2016
- Last Updated 08/03/2021
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1114377207
Products in Payments
- Progel (Device) $255.91
- Enbrel (Biological) $240.96
- RINVOQ (Biological) $191.06
- XELJANZ (Drug) $189.28
- TREMFYA (Drug) $175.11
- Cimzia (Drug) $119.27
- TAVNEOS (Drug) $111.12
- EVENITY (Biological) $107.52
- BENLYSTA (Biological) $65.03
- COSENTYX (Drug) $61.47
- SAPHNELO (Biological) $54.15
- COSENTYX (Biological) $49.57
- LUPKYNIS (Drug) $42.43
- KRYSTEXXA (Biological) $41.91
- KINERET (Drug) $38.50
- AMJEVITA (Biological) $24.04
- TALTZ (Drug) $19.43
- IDACIO (Biological) $18.83
- Tymlos (Drug) $17.82
- SKYRIZI (Biological) $17.80
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.